Cyclosporine A Pretreatment and Kidney Graft Function
Status:
Recruiting
Trial end date:
2022-09-20
Target enrollment:
Participant gender:
Summary
Organ donors included in the study are randomized to a control group or an intervention group
receiving 2.5 mg/kg of cyclosporine A before organ procurement. Harvested kidneys from these
patients are transplanted to chronic kidney insufficiency patients. According to the
pretreatment of the transplant, delayed graft function during the first week was evaluated as
well as kidney function at different timepoints and mortality during the first year after
transplantation.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborators:
Centre Hospitalier Universitaire de Nice Centre Hospitalier Universitaire de Nīmes Groupe Hospitalier Pitie-Salpetriere Hôpital de la Timone Hôtel Dieu (Nantes) Poitiers University Hospital University Hospital, Estaing University Hospital, Montpellier University Hospital, Toulouse